SensiVida's Glucose Monitoring System is an unobtrusive wearable device with a disposable microlancet chip having individually-monitored sensors that are actuated in accordance to patients test schedule. The uniqueness and advantage over the existing offerings are:
1. Automated measurements without bio-fouling or clogging.
2. Accuracy equivalent to fingerstick test since it is direct
chemical test.
3. Hygiene benefits since no blood is extracted.
4. The test is painless.
The first version of this product will target hospital use and then migrate to personable / mobile use. The glucose monitor will be comfortably worn as a band or patch. At user-defined time intervals, each needle of the array is individually deployed by the actuator, causing insertion into the patients skin. The ultra-fine tips of each microlancet are coated with glucose sensitive enzyme (e.g. Glucose oxidase) that is optically read by the system electronics. The data are calibrated so as to represent actual glucose concentrations and displayed stored, or transmitted depending on the application.
A compelling aspect of SensiVida's glucose monitor is that it provides a positive value proposition for a number of customer segments in the value chain, including health care facilities, hospitals, and patients.
Value Proposition: Health Care Facility
1. Hygiene benefits- no blood is extracted.
2. Convenient data recording-direct input to digital patient
records.
3. Minimally invasive.
4. Densely spaced sensors permit many measurements over
extended times.
5. Periodic calibration (automatic)
6. Wireless transmission to nursing station and / or alerts for
dangerous levels
7. Painless- patient friendly to children and elderly.
8. Microlancets are much less invasive-reduced puncture
skin damage.
9. Automated data recording and management improved
compliance.
10.Less disruption to patient during meals, nighttime,
activities at hospital or home.
11.More continuos operation reveals high-low glucose levels.
12.Comparable cost per test as current fingerstick test.
13.Opportunity for closed loop smart system using insulin
pump.
14.Automated timed measurements- reduced monitoring by
the medical staff.
1. Automated measurements without bio-fouling or clogging.
2. Accuracy equivalent to fingerstick test since it is direct
chemical test.
3. Hygiene benefits since no blood is extracted.
4. The test is painless.
The first version of this product will target hospital use and then migrate to personable / mobile use. The glucose monitor will be comfortably worn as a band or patch. At user-defined time intervals, each needle of the array is individually deployed by the actuator, causing insertion into the patients skin. The ultra-fine tips of each microlancet are coated with glucose sensitive enzyme (e.g. Glucose oxidase) that is optically read by the system electronics. The data are calibrated so as to represent actual glucose concentrations and displayed stored, or transmitted depending on the application.
A compelling aspect of SensiVida's glucose monitor is that it provides a positive value proposition for a number of customer segments in the value chain, including health care facilities, hospitals, and patients.
Value Proposition: Health Care Facility
1. Hygiene benefits- no blood is extracted.
2. Convenient data recording-direct input to digital patient
records.
3. Minimally invasive.
4. Densely spaced sensors permit many measurements over
extended times.
5. Periodic calibration (automatic)
6. Wireless transmission to nursing station and / or alerts for
dangerous levels
7. Painless- patient friendly to children and elderly.
8. Microlancets are much less invasive-reduced puncture
skin damage.
9. Automated data recording and management improved
compliance.
10.Less disruption to patient during meals, nighttime,
activities at hospital or home.
11.More continuos operation reveals high-low glucose levels.
12.Comparable cost per test as current fingerstick test.
13.Opportunity for closed loop smart system using insulin
pump.
14.Automated timed measurements- reduced monitoring by
the medical staff.
Site maintenance & design by Sierra Fine Art © 2016. All images on this site are the copyright property of SensiVida Medical. You may not reproduce these images in any way or for without permission. All images are registered under the copyright laws of the United States of America. Any reproductions are in violation under the copyright laws and will be prosecutable.
Our minimally invasive technology addresses a number of disease state diagnostics including allergy testing, pain-free automated glucose monitoring, and cholesterol monitoring...
SensiVida Medical Technologies
Site Under Construction
Glucose Monitor
SensiVida Cellphone
Glucose Monitor
Glucose Monitor